Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (26)
  4. Editorial (17)
  5. Review (12)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (353)
  2. Haematologica Meeting Reports (4)

Results (357)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aumento del uso y del coste de recursos sanitarios en pacientes hospitalizados seropositivos para CMV receptores de trasplantes alogénicos de células madre hematopoyéticas bajo tratamiento preventivo
    Meeting Abstract

    Fernandez-Cuesta, I.; Fang, J.; Zavras, P. D.; Su, Y.; Raval, A.; Tang, Y.; Stern, A.; Perales, M. A.; Giralt, S.; Papanicolaou, G.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Somatic mutations are shared between circulating endothelial cells (CEC) and CD34+ hematopoietic stem cells (HSC) in patients with primary myelofibrosis. Can PMF-initiating cells derive from a common HSC/EC precursor?
    Meeting Abstract

    Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; D'Adda, M.; Malagola, M.; Re, F.; Cattina, F.; Zollner, T.; Rossi, G.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Revealing transcriptome deregulation upon genomic complexity in multiple myeloma
    Meeting Abstract

    Ziccheddu, B.; Da Vià, M. C.; Dugo, M.; Lionetti, M.; Todoerti, K.; D'Agostino, M.; Neri, A.; Maura, F.; Corradini, P.; Bolli, N.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Modulation of the immune microenviroment in multiple myeloma patients treated with daratumumab-based therapy: Tumor cell-extrinsic effects of daratumumab treatment
    Meeting Abstract

    Castella, B.; D'Agostino, M.; Giannotta, C.; Oliva, S.; Genuardi, E.; Gilestro, M.; Ruggeri, M.; Corradini, P.; Ziccheddu, B.; Maura, F.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • New option for improving hematological recovery: Suppression of luteinizing hormone
    Editorial

    Elias, H. K.; Van den Brink, M. R. M.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Peripheral neuropathy and monoclonal gammopathy of undetermined significance: A population-based study including 15,351 cases and 58,619 matched controls
    Correspondence

    Rognvaldsson, S.; Steingrimsson, V.; Turesson, I.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: A systematic review and meta-analysis
    Research Letter

    Bewersdorf, J. P.; Giri, S.; Wang, R.; Williams, R. T.; Tallman, M. S.; Zeidan, A. M.; Stahl, M.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial
    Research Letter

    Ghia, P.; Coutre, S. E.; Cheson, B. D.; Barrientos, J. C.; Hillmen, P.; Pettitt, A. R.; Zelenetz, A. D.; Shreay, S.; Hallek, M.; Furman, R. R.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders
    Journal Article

    Ravandi, F.; Koumenis, I.; Johri, A.; Tallman, M.; Roboz, G. J.; Strickland, S.; Garcia-Manero, G.; Borthakur, G.; Naqvi, K.; Meyer, M.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: A position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Guidelines

    Bazarbachi, A.; Bug, G.; Baron, F.; Brissot, E.; Ciceri, F.; Dalle, I. A.; Döhner, H.; Esteve, J.; Floisand, Y.; Giebel, S.; more...
    Haematologica (2020)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: